Specializing in chemotherapy for breast cancer at Assuta Medical Center, Dr. Zhevelyuk combines oncology and radiology expertise.
Dr. Spielberg specializes in chemotherapy for breast cancer at Assuta Medical Center.
Head of the Breast Cancer Treatment Center with a fellowship at Sloan-Kettering – Dr. Jablonski-Perec brings global expertise to chemotherapy plans at Hadassah Medical Center.
Head of Oncology Department at Hadassah Medical Center with 37 years of experience in breast cancer care. Winner of 11 research grants.
Radiotherapy specialist focusing on oncology – Karen Drumea brings targeted expertise to breast cancer treatment at Rambam Medical Center.
Prof. Myriam Ben Arush is an internationally recognized specialist in Pediatric Oncology and Bone Marrow Transplantation at Ruth Rappaport Children’s Hospital.
Dr. Kim Tae Joong specializes in gynecologic oncology at Samsung Medical Center, focusing on breast cancer treatment.
Leading breast cancer expert at SOLTI, designing clinical trials for novel treatments. Dr. Prat specializes in molecular subtypes and precision medicine.
Chief Physician of the Oncology Center at Assuta Medical Center, bringing leadership and specialized expertise to breast cancer chemotherapy.
Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).
He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.
Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).
Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).
Dr. Borde has handled over 30,000 PET scans and 1,000 thyroid cancer patients at HCG Manavata Cancer Centre.
Dr. Valame specializes in targeted therapies for breast cancer, leveraging his research in molecular oncology to personalize treatment.
Dr. Lalit has performed over 10,000 major surgeries, with a focus on minimal invasive cancer surgeries and excellent outcomes.
Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.
She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.
Dr. Shruti Kate specializes in breast cancer treatment with a focus on immunotherapy and metronomic therapy for advanced cases. She trained at Tata Memorial Hospital, a leading cancer center in India.
Dr. Sridhar P.S. specializes in radiotherapy with over 30 years of experience of experience, focusing on breast cancer treatment at HCG Manavata Cancer Centre.
Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.
He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.